top of page

Mwandishi:

ULY CLINIC

Mhariri:

ULY CLINIC

Imeboreshwa:

20 Oktoba 2026, 15:06:27

Image-empty-state.png
Image-empty-state.png
Image-empty-state.png
Image-empty-state.png

Acetyl Salicylic Acid (Aspirin) and other Salicylates Poisoning

Salicylate poisoning is a life-threatening medical emergency caused by ingestion of acetylsalicylic acid (aspirin) or other salicylate-containing products such as topical liniments, methyl salicylate oils, herbal preparations, and combination medications.

Toxicity results from uncoupling of oxidative phosphorylation, leading to:

  • Increased metabolic rate

  • Excess heat production

  • Metabolic acidosis

  • Respiratory alkalosis

  • Severe electrolyte disturbances


Severe poisoning may rapidly progress to cerebral edema, pulmonary edema, shock and death if not treated aggressively.

Poisoning may be:

  • Acute – large single ingestion (often suicidal)

  • Chronic – repeated supratherapeutic dosing (common in elderly)

  • Acute-on-chronic – most dangerous


2. Toxic Dose

Dose

Severity

<150 mg/kg

Mild

150–300 mg/kg

Moderate

>300 mg/kg

Severe

>500 mg/kg

Potentially lethal

Methyl salicylate (oil of wintergreen) is extremely toxic: 5 mL ≈ 7 g aspirin equivalent


3. Risk Factors


Patient-related

  • Children

  • Elderly (chronic toxicity common)

  • Renal disease

  • Dehydration

  • Fever

  • Malnutrition

  • Pregnancy


Drug-related

  • Enteric-coated tablets (delayed toxicity)

  • Combination medications

  • Topical salicylates

  • Herbal medications


4. Pathophysiology

Salicylates produce a mixed acid-base disorder:

  1. Direct stimulation of respiratory center → respiratory alkalosis

  2. Cellular hypoxia → lactic acidosis

  3. Ketoacidosis → anion gap metabolic acidosis

  4. Uncoupling ATP → heat production and hyperthermia

Electrolyte abnormalities:

  • Hypokalemia

  • Hyponatremia

  • Hypoglycemia (brain glucose depletion even if serum normal)


5. Clinical Features


Early Signs (0–6 hours)

  • Tinnitus (classic hallmark)

  • Hearing impairment

  • Nausea and vomiting

  • Tachypnea (deep rapid breathing)

  • Sweating

  • Fever

  • Restlessness

  • Dizziness

  • Dehydration


Intermediate Signs (6–24 hours)

  • Metabolic acidosis

  • Hyperventilation

  • Confusion

  • Agitation

  • Blurred or double vision

  • Hypokalemia


Late / Severe Signs

  • Drowsiness

  • Delirium

  • Seizures

  • Coma

  • Pulmonary edema (non-cardiogenic)

  • Cerebral edema

  • Shock

  • Death


6. Diagnostic Criteria

Diagnosis is based on history + clinical findings + serum salicylate level


Classic diagnostic clues

  • Tinnitus

  • Hyperventilation

  • Mixed metabolic acidosis + respiratory alkalosis

  • Fever without infection

  • Unexplained altered mental status


7. Investigations


Essential

  • Serum salicylate level (every 2–4 hours)

  • Arterial blood gases

  • Serum electrolytes

  • Blood glucose

  • Urea & creatinine

  • Urine pH


Additional

  • Serum ketones

  • Lactate

  • Chest X-ray (pulmonary edema)

  • ECG (electrolyte disturbances)


Interpretation of Salicylate Levels

Level

Interpretation

<30 mg/dL

Mild

30–50 mg/dL

Moderate

>50 mg/dL

Severe

>100 mg/dL

Life-threatening

Important: Clinical condition is more important than level (especially chronic poisoning).


8. Management


General Principles

DO NOT intubate unless absolutely necessary(ventilation reduces respiratory compensation → sudden death)


9. Treatment


A. Emergency Stabilization (ABCDE)

  • Airway: Maintain but avoid sedation if possible

  • Breathing: Give oxygen

  • Circulation: IV access and fluids

  • Disability: Check glucose (give dextrose if low or altered consciousness)

  • Exposure: Remove contaminated clothing if topical exposure


B. Non-Pharmacological Treatment


1. Gastrointestinal Decontamination

  • Activated charcoal (within 1 hour; may repeat every 4 hours)

  • Gastric lavage if massive ingestion within 1 hour

  • Whole bowel irrigation for enteric-coated tablets


2. Fluid Resuscitation

Use isotonic saline:

  • Correct dehydration

  • Maintain urine output ≥1–2 mL/kg/hr


3. Urinary Alkalinization (Most Important Therapy)

Target urine pH >7.5


C. Pharmacological Treatment


Sodium Bicarbonate Therapy

D: Sodium bicarbonate (IV) 1–2 mEq/kg slow bolus.

Then infusion: 150 mEq sodium bicarbonate (3 ampoules of 50 ml 8.4%) in 1 litre of 5% dextrose at 150–250 ml/hour, adjusted to keep urine pH 7.5–8.0 and serum pH 7.45–7.55.

  • Fluids: A: sodium chloride 0.9% 20 ml/kg IV over 15–30 minutes if hypotensive or dehydrated, then maintenance to keep urine output 1–2 ml/kg/hour.

  • Hypoglycaemia: adults C: dextrose 50% 50 ml (25 g) IV then dextrose 5% infusion; children B: dextrose 10% 2–5 ml/kg IV then dextrose-containing fluids.

  • Hypokalaemia: C: potassium chloride 20–40 mEq per litre of IV fluid, or 10–20 mEq/hour with ECG monitoring.

  • Seizures: A: diazepam 0.15–0.2 mg/kg IV (maximum 10 mg), may repeat once after 5–10 minutes, OR C: lorazepam 0.1 mg/kg IV (maximum 4 mg).

  • Avoid acidifying agents; refer moderate–severe poisoning to intensive care early.

Goals:

  • Serum pH 7.45–7.55

  • Urine pH >7.5

Correct potassium before alkalinization


Glucose

Give dextrose even if serum glucose normal when CNS symptoms present


Electrolyte Correction

  • Potassium replacement mandatory

  • Correct hypokalemia aggressively


D. Hemodialysis (Definitive Treatment)


Indications

  • Salicylate concentration above 700 mg/litre (70 mg/dl)

  • Severe metabolic acidosis

  • Renal failure, pulmonary oedema or altered mental status

  • Failure of bicarbonate therapy


Hemodialysis rapidly:

  • Removes salicylate

  • Corrects acidosis

  • Improves survival


10. Complications

  • Cerebral edema

  • Pulmonary edema

  • Acute kidney injury

  • Hypoglycemia brain injury

  • Arrhythmias

  • Death


11. Special Populations


Children

  • Rapid deterioration

  • Early acidosis

  • Lower toxic threshold


Elderly

  • Often chronic toxicity

  • Confusion mistaken for stroke or dementia


Pregnancy

  • Fetal acidosis occurs earlier

  • Dialysis threshold lower


12. Monitoring

Repeat every 2–4 hours:

  • Salicylate level

  • ABG

  • Electrolytes

  • Glucose

  • Urine pH

Continue until levels declining AND symptoms resolved.


13. Prevention


Do’s

  • Store medicines in child-proof containers

  • Keep original packaging

  • Educate caregivers

  • Use correct dosing devices


Don’ts

  • Do not transfer tablets into other containers

  • Do not leave medicines open

  • Do not call medicine candy

  • Do not self-medicate chronic pain repeatedly


14. Prognosis

Good with early treatment.Poor prognosis if:

  • Altered consciousness

  • Pulmonary edema

  • Severe acidosis

  • Delayed presentation


References

  1. Ministry of Health, Tanzania. Standard Treatment Guidelines & National Essential Medicines List (STG-NEMLIT). 7th ed. Dodoma: MoHCDGEC; 2023.

  2. Runde TJ, Nappe TM. Salicylates Toxicity. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020.

  3. Nelson LS, Howland MA, Lewin NA, Smith SW, Goldfrank LR, Hoffman RS. Goldfrank’s Toxicologic Emergencies. 11th ed. New York: McGraw-Hill; 2019.

  4. Hoffman RS, Burns MM, Gosselin S. The poisoned patient. In: Tintinalli’s Emergency Medicine: A Comprehensive Study Guide. 9th ed. New York: McGraw-Hill; 2020.

  5. Shannon MW, Borron SW, Burns MJ. Haddad and Winchester’s Clinical Management of Poisoning and Drug Overdose. 4th ed. Philadelphia: Saunders; 2007.

  6. World Health Organization. WHO Guidelines for the Management of Common Poisonings. Geneva: WHO; 2021.

  7. American College of Medical Toxicology. Guidance document: management priorities in salicylate toxicity. J Med Toxicol. 2015;11(1):149-152.


Imeandikwa:

20 Oktoba 2026, 15:06:27

bottom of page